In 13–50%, Ductal Carcinoma In Situ (DCIS) progresses to an Invasive Ductal Carcinoma (IDC). As the individual progression risk from DCIS to IDC cannot be estimated based on clinical parameters or biomarkers, all patients with DCIS are medically treated equally. However, the role of tumor microenvironment and especially of tumor-associated fibroblasts (TAFs) appears to be critical for progression from DCIS to IDC. Based on previous work by Sameni et al. (2012), the aim of this study was to establish a 3D co-culture of primary fibroblasts and DCIS cells in vitro as a model for further investigations of TAFs’ role in breast cancer progression.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Maturitas
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Published online: August 06, 2019
© 2019 Published by Elsevier Inc.